Cover Image
市場調查報告書

中國的醫藥品產業

Pharmaceutical Industry in China

出版商 CCM 商品編碼 319015
出版日期 內容資訊 英文 65 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的醫藥品產業 Pharmaceutical Industry in China
出版日期: 2014年10月21日 內容資訊: 英文 65 Pages
簡介

中國國內製藥產業相關結構已經完全確立,並成為全球第三大醫藥品市場。2006∼2013年的製藥業界年平均成長率(CAGR)為22.6%,寫下了超越全球整體的水準之成長率。但仍擁有各企業的生產能力過小,地理性分佈不勻、生產過程重複、國內專利藥開發體制不完善、老舊化的生產技術、管理體制等許多課題,這些都是投資時的不安因素。

本報告提供中國的醫藥品產業相關分析,提供整體市場環境和政府的法規·政策,近幾年主要的市場趨勢,市場規模預測,主要的製藥業者簡介等資訊,為您概述為以下內容。

摘要整理

分析方法

第1章 商業環境

第2章 流行病學與疾病概要

第3章 整體情形

  • 主要製造商
  • 出口額·進口額
  • 國內的流通結構
  • 技術研究·開發(R&D)

第4章 市場策略

  • 打入市場策略
  • 流通制度(包含電子商務)
  • 企業合併·收購(M&A)
  • 藥價修訂
  • 醫藥分工·聯合

第5章 SWOT分析

第6章 市場預測

  • 政府的法規
  • 消費者的支出趨勢
  • 醫院數·病床數
  • 主要部門

第7章 主要醫藥品製造商簡介

  • Guangzhou Pharmaceutical Holdings Limited
  • Xiuzheng Pharmaceutical Group
  • Yangtze River Pharmaceutical Group
  • China Resources Pharmaceutical Group Limited
  • China National Pharmaceutical Group Corporation

圖表一覽

目錄

Background:

China has established a complete pharmaceutical industry chain and has become one of the largest pharmaceutical producers in the world. During 2006-2013, the Chinese pharmaceutical industry has been growing at an average annual growth rate of 22.6%, which far outpaces that in other economies in the world, making China the world's fastest growing pharmaceutical market. China was the world's ninth largest drug market in 2007, and it became the third in 2011, following the US and Japan. However, certain problems do exist in the industry, like small-scale capacity, scattered geographical layout, duplicated production processes, lack of patented domestically-developed pharmaceuticals, and outdated manufacturing technology & management structures, reminding investors to act with caution.

China's position:

China is the third largest pharmaceutical market in the world, only next to the US and Japan.

Purpose of report & value to clients:

To help customers know more about the market situation of pharmaceutical industry in China.

Applicable users:

  • Purchasers of pharmaceuticals out of China;
  • Global pharmaceutical producers;
  • Investors who want to know more about the conditions of China's pharmaceutical industry;

Report topics:

  • Relevant government regulations
  • Key suppliers
  • Mergers & acquisitions cases
  • Technology R&D
  • Drug pricing reform
  • Pharmacy trusteeship

Industry forecast:

China's pharmaceutical industry has developed rapidly during 2006-2013, attaining a CAGR of over 22% in terms of gross industrial output. China's pharmaceutical industry is projected to keep developing fast in the following years, making China the second largest market in the world at around 2020.

Methodology:

Mainly desk research

Table of Contents

Executive summary

Methodology

1 Business environment

2 Epidemiology and disease overview

3 Overall situation

  • 3-1 Key producers
  • 3-2 Export and import
  • 3-3 Domestic circulation
  • 3-4 Technology R&D

4 Market strategies

  • 4-1 Market entry
  • 4-2 Distribution system (including E-commerce)
  • 4-3 Mergers & acquisitions
  • 4-4 Drug pricing reform
  • 4-5 Pharmacy trusteeship

5 SWOT analysis

6 Market outlook

  • 6-1 Government regulations
  • 6-2 Consumer spending trends
  • 6-3 Hospitals and hospital beds
  • 6-4 Key sub-markets

7 Profiles of key pharmaceutical producers

  • 7-1 Guangzhou Pharmaceutical Holdings Limited
  • 7-2 Xiuzheng Pharmaceutical Group
  • 7-3 Yangtze River Pharmaceutical Group
  • 7-4 China Resources Pharmaceutical Group Limited
  • 7-5 China National Pharmaceutical Group Corporation

List of tables:

  • Table 2-1 Mortality by key disease type in China, 2012
  • Table 2-2 Mortality (1/100,000) of cardio-cerebrovascular disease in China, 2008-2012
  • Table 2-3 Number of the infected and death toll for main infectious diseases in China, 2009-2013
  • Table 2-4 Top 10 cancer of rural area and urban area in China in terms of morbidity, 2010
  • Table 3.1-1 Top 30 companies of pharmaceutical industry in China in terms of revenue, 2013
  • Table 3.2-1 Export and import value in the Chinese pharmaceutical industry, 2009-2013, million USD
  • Table 3.2-2 Export and import value of western medicine in China, 2009-2013, million USD
  • Table 3.2-3 Export and import value of traditional Chinese medicine in China, 2009-2013, million USD
  • Table 3.2-4 Export and import value of medical devices in China, 2009-2013, million USD
  • Table 3.3-1 Revenue of top 30 wholesale medicine enterprises in China, 2013, million USD
  • Table 3.3-2 Gross sales of top 30 retail medicine enterprises in China, 2013, million USD
  • Table 4.3-1 Transaction of mergers & acquisitions in pharmaceutical industry in China, 2006-2013
  • Table 4.3-2 Transaction of mergers & acquisitions in pharmaceutical industry in China by listed companies, 2009-2013
  • Table 4.3-3 Comparison of M&A at different stages in pharmaceutical industry in China, 2009-2013
  • Table 4.3-4 Key factors for the first stage M&A (2009-2011) in pharmaceutical industry in China
  • Table 4.3-5 Key factors for the second stage M&A (2012-2013) in pharmaceutical industry in China
  • Table 4.4-1 Pricing of different types of drugs in China
  • Table 6.3-1 Number of healthcare facilities in China, 2009-2013
  • Table 6.3-2 Number of beds by type of institution in China, 2009-2013
  • Table 6.3-3 Hospital visits and utilization rate of beds in China, 2009-2013
  • Table 7.1-1 Basic info of Guangzhou Pharmaceutical Holdings Limited
  • Table 7.2-1 Basic info of Xiuzheng Pharmaceutical Group
  • Table 7.3-1 Basic info of Yangtze River Pharmaceutical Group
  • Table 7.4-1 Basic info of China Resources Pharmaceutical Group Limited
  • Table 7.5-1 Basic info of China National Pharmaceutical Group Corporation

List of figures:

  • Figure 1-1 China's GDP and year-on-year growth rate, 2004-2013
  • Figure 1-2 China's foreign trade, 2004-2013
  • Figure 1-3 Total investment in fixed assets in China, 2004-2013
  • Figure 1-4 Investment in fixed assets under construction and newly built (farmers excluded) in China, 2004-2012
  • Figure 1-5 Foreign capital actually utilized in China, 2004-2013
  • Figure 1-6 China's outward foreign direct investment (financing excluded), 2008-2013
  • Figure 1-7 China's population, 2004-2013
  • Figure 1-8 China's demographic composition, 2004-2013
  • Figure 1-9 Per capita income of residents in China, 2004-2013
  • Figure 1-10 Total health expenditure in China, 2004-2013
  • Figure 1-11 Per capita health expenditure in China, 2004-2012
  • Figure 2-1 Morbidity and mortality of infectious diseases in China, 2004-2013
  • Figure 2-2 Top 10 countries/regions of diabetes in the world in terms of number of diabetic, 2013
  • Figure 3-1 Gross industrial output of pharmaceutical industry in China, 2006-2013
  • Figure 3-2 Global pharmaceuticals sales and its growth rate, 2004-2013
  • Figure 3-3 Structure of gross industrial output of pharmaceutical industry in China, 2013
  • Figure 3-4 Sales revenue of pharmaceutical industry in China, 2006-2013
  • Figure 3-5 Profit and profit margin of pharmaceutical industry in China, 2006-2013
  • Figure 3-6 Performance of China's pharmaceutical circulation, 2006-2013
  • Figure 3-7 Terminal medicine market size in China, 2007-2013
  • Figure 3-8 Sub-market structure of pharmaceutical industry in China in terms of value (at retail level), 2007-2013
  • Figure 3-9 Terminal medical treatment market size in China, 2007-2013
  • Figure 3-10 Market share of key categories in China's chemical pharmaceuticals in terms of value (hospital terminate), 2007-2013
  • Figure 3-11 Market share of key categories in China's TCM preparations in terms of value (hospital terminate), 2007-2013
  • Figure 3.1-1 Total revenue of top 100 companies and their share in gross sales of China's pharmaceutical industry, 2009-2013
  • Figure 3.1-2 Scale distribution of top 100 companies in China's pharmaceutical industry in terms of revenue, 2012-2013
  • Figure 3.3-1 Gross sales of China's pharmaceutical circulation industry, 2008-2013
  • Figure 3.3-2 Structure (sub-market level) of pharmaceutical market in China in terms of sales value, 2013
  • Figure 3.3-3 Structure of pharmaceutical market in China in terms of sales value at retail pharmacy level, 2013
  • Figure 3.3-4 Geographical distribution of pharmaceuticals sales in China in terms of sales value, 2013
  • Figure 3.3-5 Ownership structure of enterprises in China in terms of revenue, 2013
  • Figure 3.3-6 Distribution structure of pharmaceuticals in terms of value of distributed pharmaceuticals, 2013
  • Figure 3.3-7 Medicine circulation of direct-reporting enterprises in China, 2012-2013
  • Figure 3.3-8 Share of revenue of different scale medicine wholesale enterprises in the total of pharmaceutical market in China, 2011-2013
  • Figure 3.3-9 Number of key medicine wholesale enterprises in China in terms of revenue, 2011-2013
  • Figure 3.4-1 Pharmaceutical R&D expenditures by the public sector and private industry in China, 2007-2012
  • Figure 3.4-2 Compound annual growth rate (2006-2012) of pharmaceutical R&D expenditures of some countries/regions
  • Figure 4.2-1 Supply chain of pharmaceuticals in China
  • Figure 4.2-2 Number of participants in the supply chain of medicine in China, 2013
  • Figure 4.2-3 Number of wholesale enterprises and retail chain enterprises of medicine in China, 2009-2012
  • Figure 4.2-4 Number of retail pharmacies in China, 2008-2012
  • Figure 4.2-5 Market share of retail terminal and other terminals in China, 2007-2013
  • Figure 4.2-6 Number of provincial pharmacy leagues in China, 2009-2013
  • Figure 4.2-7 Gross sales of provincial pharmacy leagues in China, 2010-2013
  • Figure 4.2-8 Medicine enterprises (with license) and market size of E-commerce of medicine in China, 2010-2013
  • Figure 4.3-1 Number of listed companies in pharmaceutical industry in China by sub-market, 2013
Back to Top